Figure 1.
(a) Schematic illustration of the MIL-101(Fe) nMOF design, its targeted delivery, and anticancer process. (b) Confocal images showing tumor-specific cellular uptake of DOX@TTMOF at different pH. Dot plots (c) and mean fluorescence intensity (d) of quantitative flow cytometry analysis. Tumor volume (e) and body weight (f) changes in H-22 tumor-bearing mice after treatment. Reproduced with permission.[51] Copyright 2015 The Royal Society of Chemistry.